explore -WSS

explore

author：knowledge 2025-09-06 02:14:11 - browse：9285

Stain of a biopsy specimen of a rhabdoid tumor -- health coverage from STAT — Stain of a biopsy specimen of a rhabdoid tumor. Wikimedia Commons

Most targeted cancer drugs work like tranquilizer darts, snaring an overzealous gene that has spurred the cell into murderously rapid growth.

But many tumors don’t have a hyperactive gene. Like the mayhem in “Cat in the Hat,” they are enabled by parental absence. They grow because the genes that are meant to provide discipline, guiding the activity of other genes or self-destructing a cell whose DNA is too damaged, are broken or missing.

These tumors have bedeviled researchers for decades. Restoring or fixing a protein is far harder than breaking it. And that’s bad news for humanity: Cancer is far more likely to be caused by such “tumor-suppressor” genes than by one gene run amok.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： A new ‘biological computer' targets cancer while sparing healthy cells

focus

WSS

Stanford president’s abrupt resignation sparks debate

Hormonal contraceptives don’t actually treat endometriosis

Scientists grapple with ethics of stem cell research

New weight loss drugs work. But how can they best be used?

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

explore

explore

hotspot

George Santos makes 1st court appearance after pleading not guilty to 13 counts

How a scoliosis diagnosis changed the life of one young dancer

Alkermes shareholders re

Scientists grapple with ethics of stem cell research

Medicare details structure of new drug price negotiation program

JPM: CVS says Medicare Advantage patients are impacting profits

Medicare proposal to cover medical devices draws a mixed reaction

A new ‘biological computer' targets cancer while sparing healthy cells

Wildfire smoke exposes gaps in outdoor worker protections

U.K. sequencing study surfaces new findings about tumor DNA

focus

JPM: CVS says Medicare Advantage patients are impacting profits

Chronically ill young patients struggle to find fertility info

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

Telehealth startups are trying to fill the menopause care vacuum

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

There’s a way to spot data fakery. All journals should be using it

hotspot

hotspot

focus

hotspot